Reaction

Febrile Infection reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,137 reports · 59 co-occurring drugs

As of the last recalculation, Febrile Infection appears in 1,137 FAERS reports alongside 59 co-occurring drug terms. The strongest observed disproportionality signal is AMPHOTERICIN B (PRR 32.8).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Amphotericin B	22	32.8	32.8
Carfilzomib	44	29.6	29.6
Obinutuzumab	22	24.9	25.0
Azacitidine For	24	24.7	24.7
Dexamethasone Sodium Phosphate	13	23.7	23.7
Azacitidine	32	20.3	20.3
Cytarabine	63	20.3	20.3
Granisetron Hydrochloride	11	19.5	19.5
Polatuzumab Vedotin	10	18.9	18.9
Piperacillin Sodium,Tazobactam Sodium	26	18.3	18.4
Brentuximab Vedotin	10	18.0	18.0
Granisetron	10	17.6	17.6
Dalteparin Sodium	9	15.7	15.7
Bendamustine Hydrochloride	10	15.4	15.4
Meropenem	26	15.2	15.2
Cyclophosphamide Injection, Solution	126	14.5	14.5
Cyclophosphamide	126	14.5	14.5
Cyclophosphamide For Injection	126	14.5	14.5
Piperacillin And Tazobactam	10	14.4	14.4
Ribociclib	24	14.2	14.2
Blinatumomab	8	14.1	14.1
Melphalan	17	13.9	13.9
Atezolizumab	28	13.5	13.5
Posaconazole Delayed-Release	8	13.4	13.4
Fludarabine Phosphate	28	13.3	13.3
Bendamustine Hcl	11	13.1	13.1
Pemetrexed	15	13.0	13.0
Melphalan Hydrochloride	17	12.6	12.6
Teduglutide	9	12.3	12.3
Letrozole Tablets	30	11.7	11.7
Dexamethasone 1.5 Mg	161	11.6	11.6
Imatinib	11	11.5	11.5
Paclitaxel	59	11.4	11.5
Dexamethasone	161	11.4	11.4
Filgrastim	23	11.4	11.4
Venetoclax	37	11.3	11.3
Doxorubicin	52	11.1	11.2
Mesna Injection	5	11.1	11.1
Etoposide	43	11.1	11.1
Entecavir	7	11.0	11.0
Mesna	5	10.9	10.9
Gemcitabine Hydrochloride	29	10.2	10.2
Posaconazole	9	10.2	10.2
Bortezomib	47	10.0	10.0
Paclitaxel (Aibumin-Bound)	43	9.9	9.9
Pegaspargase	6	9.0	9.0
Daratumumab	19	8.8	8.8
Ranolazine	5	8.8	8.8
Pegfilgrastim	42	8.1	8.1
Dabrafenib	9	7.9	7.9
Lacosamide	15	7.5	7.5
Pemetrexed Disodium	15	7.3	7.3
Docetaxel Anhydrous	25	6.9	6.9
Docetaxel	25	6.9	6.9
Trametinib	9	6.9	6.9
Ixazomib	10	6.4	6.4
Palivizumab	5	6.0	6.0
Pomalidomide	30	5.5	5.5
Lenalidomide	107	5.0	5.0

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.